Hepatocellular Carcinoma Risk Declines but Remains High Enough for Screening in the First 7 Years After Hepatitis C Virus Cure With Direct-Acting Antivirals in Patients With Cirrhosis or High Fibrosis-4 Score
Nicole J. Kim, Philip Vutien, Kristin Berry, George N. Ioannou
Topics & Concepts
Hepatocellular carcinomaCirrhosisMedicineInternal medicineGastroenterologyScopusHepatitis C virusHepatitis CIncidence (geometry)CohortMEDLINEVirusVirologyOpticsPhysicsPolitical scienceLawHepatitis C virus researchHepatocellular Carcinoma Treatment and PrognosisLiver Disease Diagnosis and Treatment